|
|
Article: Optigenex Inc. Announces Supply and License Agreement With Suracell Inc. To Utilize the AC-11[R] Trademark and Technology for Oral Supplements In the United States, Canada and South Korea.
- Article from:
- Biotech Week
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Optigenex Inc. (Pinksheets: OPGX) announced the signing of a Supply and Trademark License Agreement with Suracell Inc. to provide its patented ingredient AC-11[R] for use in a focused nutritional and age management dietary supplement program. The agreement coupled with Suracell's marketing plans will provide another platform to introduce Optigenex's technology under the registered trademark AC-11[R] to health conscious consumers in the United States, Canada and South Korea (see also Patents).
Beginning in January 2010, Suracell will be marketing a specific dietary supplement regimen. Participants will complete lifestyle questionnaires and will be asked to provide ...
Related newspaper, magazine, and journal articles:
|
|
Article: Investigators at University of Nebraska, United ...
Biotech Week;
March 4, 2009 ;
689 words
... ... University of Nebraska, United States Department of Agriculture ... University of Nebraska, United States Dept. of Agriculture ... USA. Keywords: United States, Lincoln, Life Sciences ... article was prepared by Biotech Week editors from staff ...
|
|